Finally, the underlying comorbidities found in obese individuals such as heart, kidney, and pancreatic diseases may also be associated with the dysregulation of the ACE/ACE2 axis in these disease-related tissues [16,26]. This evidence concerns the gene ACE and pancreas disorder.